drugset / Trial / NCT01093534
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
RandomizedParallel-groupTriple-blindBasic science
Summary
The purpose is to see if solifenacin has any effect on bladder wall thickness and urine inflammatory marker measurements after 12 weeks of treatment.
Timeline
- Start
- 2010-01-19
- Primary completion
- 2011-06-23
- Completion
- 2011-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solifenacin | Small molecule | 5 mg | Oral |
| Subject | Solifenacin | Small molecule | 10 mg | Oral |